Athauda D - Search Results

1

Is Exenatide a Treatment for Parkinson's Disease?

Athauda D, Wyse R, Brundin P, Foltynie T. Athauda D, et al. J Parkinsons Dis. 2017;7(3):451-458. doi: 10.3233/JPD-171192. J Parkinsons Dis. 2017. PMID: 28777758

2

The ongoing pursuit of neuroprotective therapies in Parkinson disease.

Athauda D, Foltynie T. Athauda D, et al. Nat Rev Neurol. 2015 Jan;11(1):25-40. doi: 10.1038/nrneurol.2014.226. Epub 2014 Dec 2. Nat Rev Neurol. 2015. PMID: 25447485 Review.

3

The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action.

Athauda D, Foltynie T. Athauda D, et al. Drug Discov Today. 2016 May;21(5):802-18. doi: 10.1016/j.drudis.2016.01.013. Epub 2016 Feb 3. Drug Discov Today. 2016. PMID: 26851597 Free article. Review.

4

Challenges in detecting disease modification in Parkinson's disease clinical trials.

Athauda D, Foltynie T. Athauda D, et al. Parkinsonism Relat Disord. 2016 Nov;32:1-11. doi: 10.1016/j.parkreldis.2016.07.019. Epub 2016 Jul 31. Parkinsonism Relat Disord. 2016. PMID: 27499048 Review.

5

Insulin resistance and Parkinson's disease: A new target for disease modification?

Athauda D, Foltynie T. Athauda D, et al. Prog Neurobiol. 2016 Oct-Nov;145-146:98-120. doi: 10.1016/j.pneurobio.2016.10.001. Epub 2016 Oct 3. Prog Neurobiol. 2016. PMID: 27713036 Review.

6

Technologies Assessing Limb Bradykinesia in Parkinson's Disease.

Hasan H, Athauda DS, Foltynie T, Noyce AJ. Hasan H, et al. J Parkinsons Dis. 2017;7(1):65-77. doi: 10.3233/JPD-160878. J Parkinsons Dis. 2017. PMID: 28222539 Free PMC article. Review.

7

GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort.

Lythe V, Athauda D, Foley J, Mencacci NE, Jahanshahi M, Cipolotti L, Hyam J, Zrinzo L, Hariz M, Hardy J, Limousin P, Foltynie T. Lythe V, et al. Among authors: athauda d. J Parkinsons Dis. 2017;7(4):635-644. doi: 10.3233/JPD-171172. J Parkinsons Dis. 2017. PMID: 28777757

8

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T. Athauda D, et al. Lancet. 2017 Oct 7;390(10103):1664-1675. doi: 10.1016/S0140-6736(17)31585-4. Epub 2017 Aug 3. Lancet. 2017. PMID: 28781108 Free PMC article. Clinical Trial.

9

Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease.

Athauda D, Foltynie T. Athauda D, et al. Neuropharmacology. 2018 Jul 1;136(Pt B):260-270. doi: 10.1016/j.neuropharm.2017.09.023. Epub 2017 Sep 18. Neuropharmacology. 2018. PMID: 28927992 Review.

10

What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson's Disease: A Post Hoc Analysis.

Athauda D, Maclagan K, Budnik N, Zampedri L, Hibbert S, Skene SS, Chowdhury K, Aviles-Olmos I, Limousin P, Foltynie T. Athauda D, et al. J Parkinsons Dis. 2018;8(2):247-258. doi: 10.3233/JPD-181329. J Parkinsons Dis. 2018. PMID: 29843254 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters